帕金森病
医学
物理医学与康复
心理学
左旋多巴
精神科
萧条(经济学)
生活质量(医疗保健)
疾病
评定量表
运动障碍
标识
DOI:10.4088/jcp.ms18003br2c
摘要
Although levodopa is an effective medication for the treatment of Parkinson disease, physicians and patients face significant management challenges related to disease progression. Patients typically develop fluctuations in motor symptoms and dyskinesias. Novel treatment options may help clinicians more effectively manage patients' symptoms by extending the duration of response to medication, with improved tolerance. For many patients, nonmotor symptoms impact daily activities more than motor symptoms do. Many pharmacotherapeutic strategies are approved to address motor and nonmotor symptoms and fluctuations. A clear understanding of the advantages and potential adverse effects of each therapy can help clinicians individualize the choice and timing of medications to optimize patient response and hopefully improve quality of life.
科研通智能强力驱动
Strongly Powered by AbleSci AI